BD113vLVP
/ BDgene
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 20, 2024
CRISPR/Cas9 Instantaneous Gene Editing Therapy to Intraocular Hypertensive POAG With MYOC Mutation
(clinicaltrials.gov)
- P=N/A | N=9 | Recruiting | Sponsor: Shanghai BDgene Co., Ltd.
New trial • Glaucoma • Ophthalmology
1 to 1
Of
1
Go to page
1